Reward attended the annual academic meeting of the Stroke Society and the Tiantan International Cerebrovascular Disease Conference

A total of 27 topics were shared at the conference, including acute vascular patency treatment, secondary prevention of stroke, neurointervention, cerebral venous system diseases, intracranial and extracranial large artery disease, stroke nursing, cerebral blood flow and metabolism, dizziness/headache, antithrombotic Many clinical hot topics such as management, neuroprotection, hyperacute imaging features, new vascular imaging, and medical service/quality improvement, including clinical research methodology training, case sharing, and expert comments, allow participating scholars from various aspects benefits to meet the needs of stroke healthcare workers at all levels

Reward animal cerebral blood flow imaging solutions

• Compatible with optogenetics, recording + stimulation at the same site
• good data visualization
• Convenient and efficient
• Strong scalability
• high sensitivity
• Fully configured

• Accurate counting to ensure experimental results
• Smart and convenient, get started quickly
• Fast counting in 9 seconds, saving time and effort
• Integrated body, compact and easy to use
  
  
  
  
  • Standard procedures to improve experimental reproducibility
  • Configurable heating mantle for automated sample processing
  • Four channels work independently, can process different tissues synchronously, saving experiment time
  • One machine for two purposes, can also perform tissue homogenization
    
    

    Laser Speckle Blood Flow Imaging System

    • 2064*1544 very high resolution to observe more blood vessels
    • 100PFS to quickly obtain image data information
    • 10x optical zoom to adapt to more scenes
    
    

    As the largest, highest-level and most influential cerebrovascular disease conference in the industry in China, CSA & TISC, after 21 years of development and precipitation, continues to guide the development of stroke in China and international stroke disease management, and is also learning higher The advanced scientific research and technology challenge the difficulty of clinical management of cerebrovascular disease